Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 9/2011

01-09-2011 | Review Article

Rheumatologic manifestations of benign and malignant haematological disorders

Authors: Vinod Ravindran, Parameswaran Anoop

Published in: Clinical Rheumatology | Issue 9/2011

Login to get access

Abstract

Diseases of blood and lymphoreticular system can have multisystem manifestations. Rheumatologic involvement has been reported in association with many benign and malignant haematological disorders; these patients are equally likely to present to both clinical rheumatologists and haematologists. This review focuses on the well-described rheumatologic features, other occasionally reported rheumatologic manifestations and unusual musculoskeletal complications related to the treatment in patients with underlying haematological conditions. The aim of this review is to help increase the awareness of rheumatologic manifestations seen in the blood disorders and to highlight the potential diagnostic pitfalls.
Literature
1.
van Bokhoven MA, van Deursen CTMB, Swinkels DW (2011) Diagnosis and management of hereditary haemochromatosis. BMJ 342:218–223CrossRef
2.
Axford JS, Bomford A, Revell P, Watt I, Williams R, Hamilton EB (1991) Hip arthropathy in genetic hemochromatosis: radiographic and histologic features. Arthritis Rheum 34:357–361PubMedCrossRef
3.
Atkins CJ, McIvor J, Smith PM, Hamilton E, Williams R (1970) Chondrocalcinosis and arthropathy: studies in haemochromatosis and in idiopathic chondrocalcinosis. Q J Med 39:71–82PubMed
4.
Sahinbegovic E, Dallos T, Aigner E et al (2010) Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum 62:3792–3798PubMedCrossRef
5.
Sahinbegovic E, Dallos T, Aigner E et al (2010) Hereditary hemochromatosis as a risk factor for joint replacement surgery. Am J Med 123:659–662PubMedCrossRef
6.
Luck JV Jr, Silva M, Rodriguez-Merchan EC, Ghalambor N, Zahiri CA, Finn RS (2004) Hemophilic arthropathy. J Am Acad Orthop Surg 12:234–245PubMed
7.
Rodriguez-Merchan EC (2003) Management of musculoskeletal complications of hemophilia. Semin Thromb Hemost 29:87–96PubMedCrossRef
8.
Verma N, Valentino LA, Chawala A (2007) Arthroscopic synovectomy in haemophilia: indications, technique and results. Haemophilia 13:38–44PubMedCrossRef
9.
Barg A, Elsner A, Hefti D, Hintermann B (2010) Haemophilic arthropathy of the ankle treated by total ankle replacement: a case series. Haemophilia 16:647–655PubMed
10.
Sikkema T, Boerboom AL, Meijer K (2011) A comparison between the complications and long-term outcome of hip and knee replacement therapy in patients with and without haemophilia; a controlled retrospective cohort study. Haemophilia 17:300–303PubMedCrossRef
11.
Babhulkar SS, Pande K, Babhulkar S (1995) The hand foot syndrome in sickle-cell haemoglobinopathy. J Bone Joint Surg 77:310–312
12.
Benneth OM, Namnyak SS (1990) Bone and joint manifestations of sickle cell anemia. J Bone Joint Surg 72B:494–499
13.
Balogun RA, Obalum DC, Giwa SO, Adekoya-Cole TO, Ogo CN, Enweluzo GO (2010) Spectrum of musculoskeletal disorders in sickle cell disease in Lagos, Nigeria. J Orthop Surg Res 5:2PubMedCrossRef
14.
Styles LA, Vichinsky EP (1996) Core decompression in avascular necrosis of the hip in sickle cell disease. Am J Hematol 52:103–107PubMedCrossRef
15.
Bahebeck J, Atangana R, Techa A, Monny-Lobe M, Sosso M, Hoffmeyer P (2004) Relative rates and features of musculoskeletal complications in adult sicklers. Acta Orthop Belg 70:107–111PubMed
16.
17.
Booz MM, Hariharan V, Aradi AJ, Malki AA (1999) The value of ultrasound and aspiration in differentiating vaso-occlusive crisis and osteomyelitis in sickle cell disease patients. Clin Radiol 54:636–639PubMedCrossRef
18.
Skaggs DL, Kim SK, Greene NW, Harris D, Miller JH (2001) Differentiation between bone infarction and acute osteomyelitis in children with sickle cell disease with use of sequential radionuclide bone marrow and bone scans. J Bone Joint Surg 83-A:1810–1813PubMed
19.
20.
21.
Mody GM, Cassim B (1996) Rheumatologic features of hematologic disorders. Curr Opin Rheumatol 8:57–61PubMedCrossRef
22.
Ehrenfeld M, Gur H, Shoenfeld Y (1999) Rheumatologic features of hematologic disorders. Curr Opin Rheumatol 11:62–67PubMedCrossRef
23.
Taylor HG, Nixon N, Sheeran TP, Dawes PT (1989) Rheumatoid arthritis and chronic lymphatic leukaemia. Clin Exp Rheumatol 7:529–532PubMed
24.
Voulgari PV, Vartholomatos G, Kaiafas P, Bourantas KL, Drosos AA (2002) Rheumatoid arthritis and B-cell chronic lymphocytic leukemia. Clin Exp Rheumatol 20:63–65PubMed
25.
Senel S, Kaya E, Aydogdu I, Erkurt MA, Kuku I (2006) Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature. Rheumatol Int 26:857–861PubMedCrossRef
26.
Douer D, Weinberger A, Djaldetti M, Pinkhas J, Varies D (1977) Successful treatment of severe bone pain and acute arthritis in chronic myelomonocytic leukaemia by cytosine arabinoside. Ann Rheum Dis 36:192–193PubMedCrossRef
27.
Aguilera Cros C, Gutierrez I, Gomez JP (2006) Leukemic infiltration of the knee. J Rheumatol 33:1709PubMed
28.
Vernhes JP, Schaeverbeke T, Fach J, Lequen L, Bannwarth B, Dehais J (1997) Chronic immunity-driven polyarthritis in hairy cell leukemia. Report of a case and review of the literature. Rev Rhum Engl Ed 64:578–581PubMed
29.
Raimbourg J, Cormier G, Varin S, Tanguy G, Bleher Y, Maisonneuve H (2009) Hairy-cell leukemia with inaugural joint manifestations. Joint Bone Spine 76:416–420PubMedCrossRef
30.
Sattar MA, Cawley MI (1982) Arthritis associated with hairy cell leukaemia. Ann Rheum Dis 41:289–291PubMedCrossRef
31.
von Knorring J, Selroos O (1977) Polymyalgia rheumatica and chronic lymphatic leukaemia. Scand J Rheumatol 6:145–147CrossRef
32.
Hamidou MA, Boumalassa A, Larroche C, El Kouri D, Bletry O, Grolleau JY (2001) Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia. Semin Arthritis Rheum 31:119–126PubMedCrossRef
33.
Segawa F, Shimizu Y, Saito E, Kinoshita M (1995) Behcet's disease induced by interferon therapy for chronic myelogenous leukemia. J Rheumatol 22:1183–1184PubMed
34.
Budak-Alpdogan T, Demircay Z, Alpdogan O, Direskeneli H, Ergun T, Bayik M, Akoglu T (1997) Behcet’s disease in patients with chronic myelogenous leukemia: possible role of interferon alpha treatment in the occurrence of Behcet’s symptoms. Ann Hematol 74:45–48PubMedCrossRef
35.
Vaiopoulos G, Terpos E, Viniou N, Nodaros K, Rombos J, Loukopoulos D (2001) Behcet’s disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature. Am J Hematol 66:57–58PubMedCrossRef
36.
Yoe J, Gause BL, Curti BD et al (1998) Development of rheumatoid arthritis after treatment of large granular lymphocyte leukemia with deoxycoformycin. Am J Hematol 57:253–257PubMedCrossRef
37.
Avina-Zubieta JA, Galindo-Rodriguez G, Lavalle C (1998) Rheumatic manifestations of hematologic disorders. Curr Opin Rheumatol 10:86–90PubMedCrossRef
38.
Castro M, Conn DL, Su WP, Garton JP (1991) Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol 18:721–727PubMed
39.
Chandran G, Ahern MJ, Seshadri P, Coghlan D (1996) Rheumatic manifestations of the myelodysplastic syndromes: a comparative study. Aust New Zeal J Med 26:683–688PubMedCrossRef
40.
Mok CC, Lau CS, Kumana CR (1996) Polymyalgia rheumatica as the rheumatological manifestation of myelodysplastic syndrome in a Chinese patient. Br J Rheumatol 35:496–497PubMedCrossRef
41.
Kohli M, Bennett RM (1994) An association of polymyalgia rheumatica with myelodysplastic syndromes. J Rheumatol 21:1357–1359PubMed
42.
Kuzmich PV, Ecker GA, Karsh J (1994) Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases. J Rheumatol 21:1649–1654PubMed
43.
Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483–489PubMedCrossRef
44.
Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM (2004) Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford) 43:626–632CrossRef
45.
Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W (1995) Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 91:403–408PubMedCrossRef
46.
Yu T, Weinreb N, Wittman R, Wasserman LR (1976) Secondary gout associated with chronic myeloproliferative disorders. Semin Arthritis Rheum 5:247–256PubMedCrossRef
47.
Falcini F, Bardare M, Cimaz R, Lippi A, Corona F (1998) Arthritis as a presenting feature of non-Hodgkin’s lymphoma. Arch Dis Child 78:367–370PubMedCrossRef
48.
McDonagh JE, Clarke F, Smith SR, Kesteven P, Walker DJ (1994) Non-Hodgkin’s lymphoma presenting as polyarthritis. Br J Rheumatol 33:79–84PubMedCrossRef
49.
Nishiya K, Tanaka Y (1997) Co-existence of non-Hodgkin’s lymphoma in the leukemic phase and polyarthritis simulating rheumatoid arthritis. Int Med 36:227–231CrossRef
50.
Gran JT, Sund S, Langholm R (1994) Small cell pleomorphic T-cell lymphoma presenting with cutaneous vasculitis. Clin Rheumatol 13:628–630PubMedCrossRef
51.
Walker UA, Herbst EW, Ansorge O, Peter HH (1994) Intravascular lymphoma simulating vasculitis. Rheumatol Int 14:131–133PubMedCrossRef
52.
McCarty DJ, O'Duffy JD, Pearson L, Hunter JB (1985) Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 254:2763–2767PubMedCrossRef
53.
Olive A, del Blanco J, Pons M, Vaquero M, Tena X (1997) The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. The Catalan Group for the Study of RS3PE. J Rheumatol 24:333–336PubMed
54.
Jorgensen C, Guerin B, Ferrazzi V, Bologna C, Sany J (1996) Arthritis associated with monoclonal gammapathy: clinical characteristics. Br J Rheumatol 35:241–243PubMedCrossRef
55.
Vitali C, Baglioni P, Vivaldi I, Cacialli R, Tavoni A, Bombardieri S (1991) Erosive arthritis in monoclonal gammopathy of uncertain significance: report of four cases. Arthritis Rheum 34:1600–1605PubMedCrossRef
56.
Alpay N, Artim-Esen B, Kamali S, Gul A, Kalayoglu-Besişik S (2009) Amyloid arthropathy mimicking seronegative rheumatoid arthritis in multiple myeloma: case reports and review of the literature. Amyloid 16:226–231PubMedCrossRef
57.
Fujishima M, Komatsuda A, Imai H, Wakui H, Watanabe W, Sawada K (2003) Amyloid arthropathy resembling seronegative rheumatoid arthritis in a patient with IgD-kappa multiple myeloma. Int Med 42:121–124CrossRef
58.
Miller MI, Hoppmann RA, Pisko EJ (1987) Multiple myeloma presenting with primary meningococcal arthritis. Am J Med 82:1257–1258PubMedCrossRef
59.
Berthaud V, Milder J, el-Sadr W (1993) Multiple myeloma presenting with Hemophilus influenzae septic arthritis: case report and review of the literature. J Natl Med Assoc 85:626–628PubMed
60.
Afeltra A, Amoroso A, Garzia P, Addessi MA, Pulsoni A, Bonomo L (1997) Systemic lupus erythematosus and multiple myeloma: a rare association. Semin Arthritis Rheum 26:845–849PubMedCrossRef
61.
Maamar M, Tazi Mezalek Z, Harmouche H, Adnaoui M, Aouni M, Maaouni A (2008) Systemic lupus erythematosus and multiple myeloma: an uncommon association. Two cases and literature review. Clin Exp Rheumatol 26:667–670PubMed
62.
Terpos E, Angelopoulou MK, Variami E, Meletis JC, Vaiopoulos G (2000) Sjögren’s syndrome associated with multiple myeloma. Ann Hematol 79:449–451PubMedCrossRef
63.
Rodriguez-Cuartero A, Salas-Galan A (1997) Sjögren’s syndrome and multiple myeloma. Eur J Cancer 33:167–168PubMedCrossRef
64.
Viard JP, Lesavre P, Boitard C, Noel LH, Roth A, Said G, Bach JF (1988) POEMS syndrome presenting as systemic sclerosis. Clinical and pathologic study of a case with microangiopathic glomerular lesions. Am J Med 84:524–528PubMedCrossRef
65.
Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR et al (2003) POEMS syndrome: definitions and long-term outcome. Blood 101:2496–2506PubMedCrossRef
66.
Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M (1974) Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57:775–788PubMedCrossRef
67.
Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N (1966) Cryoglobulinemia—a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40:837–856PubMedCrossRef
68.
Cohen SJ, Pittelkow MR, Su WP (1991) Cutaneous manifestations of cryoglobulinemia: clinical and histopathologic study of seventy-two patients. J Am Acad Dermatol 25:21–27PubMedCrossRef
69.
Sherer Y, Shoenfeld Y (1998) Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant 22:873–881PubMedCrossRef
70.
Daikeler T, Tyndall A (2007) Autoimmunity following haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 20:349–360PubMedCrossRef
71.
Barnabe CC, LeClercq SA, Fitzgerald AA (2009) The development of inflammatory arthritis and other rheumatic diseases following stem cell transplantation. Semin Arthritis Rheum 39:55–60PubMedCrossRef
72.
Imamura R, Inoue H, Kato K et al (2002) Development of rheumatoid arthritis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 30:527–529PubMedCrossRef
73.
Bohgaki T, Atsumi T, Koike T (2008) Autoimmune disease after autologous hematopoietic stem cell transplantation. Autoimmun Rev 7:198–203PubMedCrossRef
74.
Kuderer NM, Dale DC, Crawford J, Lyman GH (2007) Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review. J Clin Oncol 25:3158–3167PubMedCrossRef
75.
Passos de Souza E, Evangelista Segundo PT, Jose FF, Lemaire D, Santiago M (2001) Rheumatoid arthritis induced by alpha-interferon therapy. Clin Rheumatol 20:297–299PubMedCrossRef
76.
Gebhard KL, Maibach HI (2001) Relationship between systemic corticosteroids and osteonecrosis. Am J Clin Dermatol 2:377–388PubMedCrossRef
77.
Marsh JC, Zomas A, Hows JM, Chapple M, Gordon-Smith EC (1993) Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone. Br J Haematol 84:731–735PubMedCrossRef
Metadata
Title
Rheumatologic manifestations of benign and malignant haematological disorders
Authors
Vinod Ravindran
Parameswaran Anoop
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 9/2011
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1799-x

Other articles of this Issue 9/2011

Clinical Rheumatology 9/2011 Go to the issue

Original Article

Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis

Original Article

Coping style as a predictor of compliance with referral to active rehabilitation in whiplash patients

Original Article

Spontaneous skin regression and predictors of skin regression in Thai scleroderma patients

Original Article

Performance of tuberculin skin test and interferon gamma assay for the diagnosis of latent tuberculosis infection in juvenile idiopathic arthritis

Original Article

Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis

Case Based Review

Yoga for low back pain: a systematic review of randomized clinical trials
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits